Lanreotide Autogel ® in the Management of Acromegaly

By Molitch Mark E.  

Drugs, Vol. 68, Iss. 5, 2008-01 ,pp. : 724-724

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetic Meta-Analysis of Denosumab in Healthy Subjects and Postmenopausal Women with Osteopenia or Osteoporosis

By Sutjandra Liviawati   Rodriguez Rachelle D.   Doshi Sameer   Mark   Peterson Mark C.   Jang Graham R.   Chow Andrew T.   Pérez-Ruixo Juan José  

Clinical Pharmacokinetics, Vol. 50, Iss. 12, 2011-12 ,pp. : 793-807

Adis International

Access to resources Recommend Favorite

How many subjects are necessary for population pharmacokinetic experiments? Confidence interval approach

By Ogungbenro Kayode   Aarons Leon  

European Journal of Clinical Pharmacology, Vol. 64, Iss. 7, 2008-07 ,pp. : 705-713

Springer Publishing Company

Access to resources Recommend Favorite

A Population Pharmacokinetic/Pharmacodynamic Analysis of Regadenoson, an Adenosine A 2A -Receptor Agonist, in Healthy Male Volunteers

By Gordi Toufigh  

Clinical Pharmacokinetics, Vol. 45, Iss. 12, 2006-01 ,pp. : 1201-1212

Adis International

Access to resources Recommend Favorite

Lanreotide Autogel®: A Review of its Use in the Management of Acromegaly

By Croxtall Jamie D.   Scott Lesley J.  

Drugs, Vol. 68, Iss. 5, 2008-01 ,pp. : 711-723

Adis International

Access to resources Recommend Favorite